Simcere Pharmaceutical Group Limited (FRA:S2P)
1.250
+0.030 (2.46%)
At close: Jan 30, 2026
48.81% (1Y)
| Market Cap | 3.26B +57.2% |
| Revenue (ttm) | 844.70M +12.1% |
| Net Income | 104.62M |
| EPS | 0.04 |
| Shares Out | n/a |
| PE Ratio | 31.13 |
| Forward PE | 21.80 |
| Dividend | 0.02 (1.57%) |
| Ex-Dividend Date | Jun 18, 2025 |
| Volume | 500 |
| Average Volume | 30 |
| Open | 1.250 |
| Previous Close | 1.220 |
| Day's Range | 1.250 - 1.250 |
| 52-Week Range | 0.820 - 1.600 |
| Beta | n/a |
| RSI | 45.40 |
| Earnings Date | Mar 20, 2026 |